SDX-101, the R-enantiomer of etodolac, induces cytotoxicity, overcomes drug resistance, and enhances the activity of dexamethasone in multiple myeloma (Q40440440)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | SDX-101, the R-enantiomer of etodolac, induces cytotoxicity, overcomes drug resistance, and enhances the activity of dexamethasone in multiple myeloma |
scientific article |
Statements
1 reference
SDX-101, the R-enantiomer of etodolac, induces cytotoxicity, overcomes drug resistance, and enhances the activity of dexamethasone in multiple myeloma (English)
1 reference
1 reference
Kenneth C Anderson
1 reference
Shaji Kumar
1 reference
Pierfrancesco Tassone
1 reference
Hiroshi Yasui
1 reference
Teru Hideshima
1 reference
Makoto Hamasaki
1 reference
Norihiko Shiraishi
1 reference
Kenji Ishitsuka
1 reference
Noopur Raje
1 reference
Yu-Tzu Tai
1 reference
Klaus Podar
1 reference
Dharminder Chauhan
1 reference
Lorenzo M Leoni
1 reference
Sarath Kanekal
1 reference
Gary Elliott
1 reference
Nikhil C Munshi
1 reference
31 March 2005
1 reference
1 reference
106
1 reference
2
1 reference
706-712
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference